Volume 17, Issue 4 (Paramedical Sciences and Military Health (winter 2023) 2022)                   Paramedical Sciences and Military Health 2022, 17(4): 1-3 | Back to browse issues page

XML Persian Abstract Print

Iranshahr University of Medical Sciences , beh.foroutan@gmail.com
Abstract:   (503 Views)
Despite the significant effect in the use of drugs in diseases, even with the correct diagnosis, not all patients respond favorably to the drugs. Also, some patients suffer more from the side effects of drugs. Pharmacogenetic studies have shown that the polymorphism of drug metabolizing enzymes, transporters and receptors are involved in the different responses of patients to drugs. Considering the complexity of drug therapy, a broader genomics approach with the aim of finding new drug targets and optimizing treatment for each patient seems necessary. However, pharmacogenomics has been able to provide clinical solutions in several clinical situations such as the use of Herceptin in women with breast cancer. Another example is mercaptopurine, which is recommended to patients with acute lymphoblastic leukemia. Some patients have a genetic variant that interferes with their ability to process this drug. This processing problem can cause severe side effects unless the standard amount is adjusted according to the patient's genetic makeup.
Full-Text [PDF 671 kb]   (803 Downloads)    
Type of Study: Applicable | Subject: article abstracts
Received: 2023/01/25 | Accepted: 2023/04/10 | Published: 2023/03/20

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.